Cara Therapeutics | CARA - Market Capitalization


Cara Therapeutics reported $191M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 221M May/2026
Alterity Therapeutics Limited AUD 40M 16M May/2026
Cara Therapeutics USD 366M 338M Sep/2025
Cassava Sciences USD 96M 45M Dec/2025
Chugai Pharma JPY 14.46T 617.89B Mar/2026
Cipla INR 1.15T 162.77B May/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Halozyme Therapeutics USD 8.56B 905M May/2026
J&J USD 579.15B 78.91B Mar/2026
Neurocrine Biosciences USD 15.15B 1.9B May/2026
Pacira USD 915M 149M Mar/2026
Pfizer USD 147.4B 6.42B May/2026
RedHill Biopharma USD 12M 17M Jun/2024
Supernus Pharmaceuticals USD 2.82B 155M May/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024